Vanguard Asset Management »

Evommune shares owned by Vanguard Asset Management

Quarter-by-quarter ownership of Evommune (EVMN) shares owned by Vanguard Asset Management from 13F filings

Historical chart of Vanguard Asset Management investment in Evommune

Tip: Access up to 7 years of quarterly data

All positions including Evommune held by Vanguard Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Evommune by Vanguard Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $106k 8.0k 13.29

More positions owned by Vanguard Asset Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Astrazeneca Ord (AZN)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Micron Technology (MU)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Advanced Micro Devices (AMD)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for Vanguard Asset Management

Top funds holding Evommune

EQT Fund Management S.a r.l.
RA Capital Management
Pivotal bioVenture Partners Investment Advisor
Jpmorgan Chase & Co
Rtw Investments
Nan Fung Group Holdings
Point72 Asset Management
Andera Partners
SymBiosis Capital Partners
Eventide Asset Management
T. Rowe Price Associates
Vestal Point Capital
Henderson Group
Jupiter Topco
BlackRock

View all funds holding Evommune